Evidence map›Paper›PMID 35755335›Full record

ArticleACS omega2022

Development of

Asmaa A Amer, Reda S Mohammed, Yasmein Hussein, Ahmed S M Ali, Ashraf A Khalil

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Pharmacological and Chemical Analysis ofPlants (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Asmaa A AmerDepartment of Pharmacognosy, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.ORCID https://orcid.org/0000-0001-7208-3288
Reda S MohammedDepartment of Pharmacognosy, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
Yasmein HusseinNanotechnology Research Center (NTRC), The British University in Egypt (BUE), El-Shorouk, Cairo 11837, Egypt.
Ahmed S M AliNanotechnology Research Center (NTRC), The British University in Egypt (BUE), El-Shorouk, Cairo 11837, Egypt.ORCID https://orcid.org/0000-0002-0001-8222
Ashraf A KhalilInstitute of Biotechnology & Genetic Engineering, City of Scientific Research & Technology Applications, Borg Elarab, Alexandria 5220211, Egypt.
British University in Egypt · EGNational Research Centre · EGCity of Scientific Research and Technological Applications · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35755335
PMCPMC9218980
OpenAlexW4281616003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.